Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
复制标题
DOI:
10.1016/j.neurobiolaging.2008.01.005
复制
发表时间:
2009-11-01
影响因子:
4.2
通讯作者:
Bruni, Amalia C.
中科院分区:
文献类型:
--
作者:
Bernardi, Livia;Tomaino, Carmine;Bruni, Amalia C.
Background: Frontotemporal dementia is a clinically and genetically heterogeneous syndrome. Mutations in two genes, Microtubule Associated Protein Tau (MAPT) and Progranulin (PGRN), and rarely Presenilin mutations, have been causally linked to this disorder.Objective: To investigate the presence of PGRN, PSEN1, PSEN2 and APP mutations in a group of familial early-onset frontotemporal dementia (f-EOFTD) patients negative for MAPT gene mutations.Subjects and methods: We prospectively studied 17 unrelated subjects diagnosed with f-EOFTD (one case neuropathologically confirmed as FTD-Ub+). Among these subjects eight belonged to eight autosomal dominant families unrelated to each other, and nine had at least one first degree relative affected by dementia.Results: We identified two novel heterozygous mutations in two unrelated patients, Cys139Arg in the PGRN gene and Val412Ile in the PSEN1 gene.Conclusions: Early-onset f-FTD remains a heterogeneous disorder from a genetic point of view. PGRN mutation frequency was low in our sample. The presence of a novel PSEN1 mutation suggests that presenilin molecular studies should be per-formed when screening for MAPT and PGRN genes is negative. (C) 2008 Elsevier Inc. All rights reserved.